(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 22.47% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.95%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Natera's revenue in 2024 is $1,082,571,000.On average, 6 Wall Street analysts forecast NTRA's revenue for 2024 to be $161,517,403,982, with the lowest NTRA revenue forecast at $160,499,294,321, and the highest NTRA revenue forecast at $162,156,092,393. On average, 6 Wall Street analysts forecast NTRA's revenue for 2025 to be $193,997,650,158, with the lowest NTRA revenue forecast at $184,602,566,570, and the highest NTRA revenue forecast at $210,744,231,783.
In 2026, NTRA is forecast to generate $233,723,610,471 in revenue, with the lowest revenue forecast at $226,167,427,833 and the highest revenue forecast at $248,603,033,801.